Ensuring Sufficient Supply of Testing Act
- Last Action
- 6/9/2023
Actions
- 2023-06-09Referred to the Subcommittee on Health.
- 2023-06-06Referred to the House Committee on Energy and Commerce.
- 2023-06-06Introduced in House
- 2023-06-06Introduced in House
CRS Summary
As of 2023-06-06 (00)
Ensuring Sufficient Supply of Testing Act
This bill expressly authorizes the Department of Health and Human Services (HHS) to enter into certain contracts and cooperative agreements with clinical laboratories as part of maintaining the Strategic National Stockpile. The Strategic National Stockpile consists of drugs, vaccines, medical products, and other supplies that may be deployed to respond to bioterrorist attacks or other public health emergencies.
Current law permits HHS to enter into specified types of contracts and cooperative agreements with vendors (e.g., manufacturers and distributors of medical products) for managing inventory of and ensuring production capacity for supplies needed for the stockpile. The bill specifies that clinical laboratories may participate as vendors in those types of contracts and agreements.
Cosponsors (1)
- Debbie Dingell (D-MI)
Subjects
- Health technology, devices, supplies
- Medical tests and diagnostic methods
- Public contracts and procurement
- Strategic materials and reserves
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.